table of content
1 Study Coverage
1.1 Next Generation Cancer Diagnostic Devices Product Introduction
1.2 Market by Type
1.2.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Market by Application
1.3.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Next Generation Cancer Diagnostic Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Next Generation Cancer Diagnostic Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Next Generation Cancer Diagnostic Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Next Generation Cancer Diagnostic Devices Sales by Region
2.4.1 Global Next Generation Cancer Diagnostic Devices Sales by Region (2017-2022)
2.4.2 Global Sales Next Generation Cancer Diagnostic Devices by Region (2023-2028)
2.5 Global Next Generation Cancer Diagnostic Devices Revenue by Region
2.5.1 Global Next Generation Cancer Diagnostic Devices Revenue by Region (2017-2022)
2.5.2 Global Next Generation Cancer Diagnostic Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Next Generation Cancer Diagnostic Devices Sales by Manufacturers
3.1.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Next Generation Cancer Diagnostic Devices in 2021
3.2 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturers
3.2.1 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostic Devices Revenue in 2021
3.3 Global Next Generation Cancer Diagnostic Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Next Generation Cancer Diagnostic Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Next Generation Cancer Diagnostic Devices Sales by Type
4.1.1 Global Next Generation Cancer Diagnostic Devices Historical Sales by Type (2017-2022)
4.1.2 Global Next Generation Cancer Diagnostic Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2017-2028)
4.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type
4.2.1 Global Next Generation Cancer Diagnostic Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Next Generation Cancer Diagnostic Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2017-2028)
4.3 Global Next Generation Cancer Diagnostic Devices Price by Type
4.3.1 Global Next Generation Cancer Diagnostic Devices Price by Type (2017-2022)
4.3.2 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Next Generation Cancer Diagnostic Devices Sales by Application
5.1.1 Global Next Generation Cancer Diagnostic Devices Historical Sales by Application (2017-2022)
5.1.2 Global Next Generation Cancer Diagnostic Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2017-2028)
5.2 Global Next Generation Cancer Diagnostic Devices Revenue by Application
5.2.1 Global Next Generation Cancer Diagnostic Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Next Generation Cancer Diagnostic Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2017-2028)
5.3 Global Next Generation Cancer Diagnostic Devices Price by Application
5.3.1 Global Next Generation Cancer Diagnostic Devices Price by Application (2017-2022)
5.3.2 Global Next Generation Cancer Diagnostic Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Next Generation Cancer Diagnostic Devices Market Size by Type
6.1.1 North America Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028)
6.1.2 North America Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2028)
6.2 North America Next Generation Cancer Diagnostic Devices Market Size by Application
6.2.1 North America Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028)
6.2.2 North America Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2028)
6.3 North America Next Generation Cancer Diagnostic Devices Market Size by Country
6.3.1 North America Next Generation Cancer Diagnostic Devices Sales by Country (2017-2028)
6.3.2 North America Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Next Generation Cancer Diagnostic Devices Market Size by Type
7.1.1 Europe Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028)
7.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2028)
7.2 Europe Next Generation Cancer Diagnostic Devices Market Size by Application
7.2.1 Europe Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028)
7.2.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2028)
7.3 Europe Next Generation Cancer Diagnostic Devices Market Size by Country
7.3.1 Europe Next Generation Cancer Diagnostic Devices Sales by Country (2017-2028)
7.3.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Next Generation Cancer Diagnostic Devices Market Size by Type
8.1.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Next Generation Cancer Diagnostic Devices Market Size by Application
8.2.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Next Generation Cancer Diagnostic Devices Market Size by Region
8.3.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Next Generation Cancer Diagnostic Devices Market Size by Type
9.1.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028)
9.1.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2028)
9.2 Latin America Next Generation Cancer Diagnostic Devices Market Size by Application
9.2.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028)
9.2.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2028)
9.3 Latin America Next Generation Cancer Diagnostic Devices Market Size by Country
9.3.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Country (2017-2028)
9.3.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size by Type
10.1.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size by Application
10.2.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size by Country
10.3.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche Holding Ltd.?Switzerland)
11.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
11.1.2 Roche Holding Ltd.?Switzerland) Overview
11.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Holding Ltd.?Switzerland) Recent Developments
11.2 Abbott Laboratories(US)
11.2.1 Abbott Laboratories(US) Corporation Information
11.2.2 Abbott Laboratories(US) Overview
11.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories(US) Recent Developments
11.3 Siemens Healthcare(Germany)
11.3.1 Siemens Healthcare(Germany) Corporation Information
11.3.2 Siemens Healthcare(Germany) Overview
11.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Siemens Healthcare(Germany) Recent Developments
11.4 Agilent Technologies Inc(Germany)
11.4.1 Agilent Technologies Inc(Germany) Corporation Information
11.4.2 Agilent Technologies Inc(Germany) Overview
11.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Agilent Technologies Inc(Germany) Recent Developments
11.5 Illumina Inc.(US)
11.5.1 Illumina Inc.(US) Corporation Information
11.5.2 Illumina Inc.(US) Overview
11.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Illumina Inc.(US) Recent Developments
11.6 Becton Dickinson and Co.(US)
11.6.1 Becton Dickinson and Co.(US) Corporation Information
11.6.2 Becton Dickinson and Co.(US) Overview
11.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton Dickinson and Co.(US) Recent Developments
11.7 QIAGEN N.V.(Germany)
11.7.1 QIAGEN N.V.(Germany) Corporation Information
11.7.2 QIAGEN N.V.(Germany) Overview
11.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 QIAGEN N.V.(Germany) Recent Developments
11.8 Affymetrix Inc.(US)
11.8.1 Affymetrix Inc.(US) Corporation Information
11.8.2 Affymetrix Inc.(US) Overview
11.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Affymetrix Inc.(US) Recent Developments
11.9 Johnson & Johnson(US)
11.9.1 Johnson & Johnson(US) Corporation Information
11.9.2 Johnson & Johnson(US) Overview
11.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson(US) Recent Developments
11.10 Thermo Fisher Scientific Inc.(US)
11.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
11.10.2 Thermo Fisher Scientific Inc.(US) Overview
11.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Thermo Fisher Scientific Inc.(US) Recent Developments
11.11 GE Healthcare(England)
11.11.1 GE Healthcare(England) Corporation Information
11.11.2 GE Healthcare(England) Overview
11.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GE Healthcare(England) Recent Developments
11.12 Life Technologies Corp.(US)
11.12.1 Life Technologies Corp.(US) Corporation Information
11.12.2 Life Technologies Corp.(US) Overview
11.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Life Technologies Corp.(US) Recent Developments
11.13 Luminex Corp.(US)
11.13.1 Luminex Corp.(US) Corporation Information
11.13.2 Luminex Corp.(US) Overview
11.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Luminex Corp.(US) Recent Developments
11.14 Cepheid Inc.(US)
11.14.1 Cepheid Inc.(US) Corporation Information
11.14.2 Cepheid Inc.(US) Overview
11.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cepheid Inc.(US) Recent Developments
11.15 Allegro Diagnostics Corp.(Brazil)
11.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
11.15.2 Allegro Diagnostics Corp.(Brazil) Overview
11.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Allegro Diagnostics Corp.(Brazil) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Next Generation Cancer Diagnostic Devices Industry Chain Analysis
12.2 Next Generation Cancer Diagnostic Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Next Generation Cancer Diagnostic Devices Production Mode & Process
12.4 Next Generation Cancer Diagnostic Devices Sales and Marketing
12.4.1 Next Generation Cancer Diagnostic Devices Sales Channels
12.4.2 Next Generation Cancer Diagnostic Devices Distributors
12.5 Next Generation Cancer Diagnostic Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Next Generation Cancer Diagnostic Devices Industry Trends
13.2 Next Generation Cancer Diagnostic Devices Market Drivers
13.3 Next Generation Cancer Diagnostic Devices Market Challenges
13.4 Next Generation Cancer Diagnostic Devices Market Restraints
14 Key Findings in The Global Next Generation Cancer Diagnostic Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
